Another Blog:
https://cureresearch4type1diabetes.blogspot.com/2025/12/fecal-transplantation-starts-phase-ii.html
#T1D #type1diabetes #t1dresearch
(Reminder: this blog covers treatments being tested on people aimed at curing, preventing or delaying T1D, even if they are gross. 😀)
Fecal Transplantation Starts A Phase-II Trial (FACT-T1D)

The Fecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus (FACT-T1D) trial is testing a new approach to treating or curing t...

Another blog!
#T1D #TYPE1DIABETES #t1dresearch
https://cureresearch4type1diabetes.blogspot.com/2025/10/immunostem-starts-phase-i-clinical.html
IMMUNOSTEM starts a Phase-I Clinical Trial in Honeymooners
IMMUNOSTEM technology refers to using a virus (specifically a lentivirus) to deliver a new gene into cells, which will then produce a specific protein PD-L1 (Programmed Death-Ligand 1). This protein plays a key role in the immune system by telling T-cells not to attack a specific other cell (in this case, beta cells). ...
IMMUNOSTEM starts a Phase-I Clinical Trial in Honeymooners

IMMUNOSTEM technology refers to using a virus (specifically a lentivirus) to deliver a new gene into cells, which will then produce a specif...

RTing JDRF Post 17/11/22: 📹 WATCH: Our Director of Research Partnerships @coracle1 explains why we are so excited that @US_FDA has approved #teplizumab as the first disease-modifying drug for #Type1Diabetes. 🎉

Read more: https://jdrf.org.uk/news/worlds-first-type-1-diabetes-disease-modifying-drug-approved-in-the-us/ #T1D #GBDoc #T1Dresearch

World’s first type 1 diabetes disease-modifying drug approved in the US - JDRF, the type 1 diabetes charity

Teplizumab, an immunotherapy drug proven to delay the onset of type 1 by up to 3 years in high-risk individuals, has been approved.

JDRF, the type 1 diabetes charity